Risk stratification for sudden cardiac death: Is there a clinical role for T wave alternans?
- 31 August 2009
- journal article
- review article
- Published by Elsevier in Heart Rhythm
- Vol. 6 (8) , S56-S61
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Targeted SERCA2a Gene Expression Identifies Molecular Mechanism and Therapeutic Target for Arrhythmogenic Cardiac AlternansCirculation: Arrhythmia and Electrophysiology, 2009
- Can we alternate between T-wave alternans testing methods?Heart Rhythm, 2009
- Explaining the clinical manifestations of T wave alternans in patients at risk for sudden cardiac deathHeart Rhythm, 2009
- Role of Microvolt T-Wave Alternans in Assessment of Arrhythmia Vulnerability Among Patients With Heart Failure and Systolic DysfunctionCirculation, 2008
- Intracellular Ca Alternans: Coordinated Regulation by Sarcoplasmic Reticulum Release, Uptake, and LeakBiophysical Journal, 2008
- Cardiac Alternans Do Not Rely on Diastolic Sarcoplasmic Reticulum Calcium Content FluctuationsCirculation Research, 2006
- Microvolt T-Wave Alternans and the Risk of Death or Sustained Ventricular Arrhythmias in Patients With Left Ventricular DysfunctionJACC, 2006
- Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection FractionNew England Journal of Medicine, 2002
- Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarctionThe Lancet, 1998
- Effects of verapamil on canine Purkinje fibres and ventricular muscle fibres with particular reference to the alternation of action potential duration after a sudden increase in driving rateCardiovascular Research, 1979